{"product_id":"s23-60x10-mg","title":"S23 100x10mg","description":"\u003cp data-end=\"664\" data-start=\"38\"\u003e\u003cspan\u003e\u003cstrong\u003e\u003cstrong data-end=\"392\" data-start=\"377\"\u003e\u003cspan style=\"color: rgb(255, 42, 0);\"\u003e                                            \u003cspan style=\"text-decoration: underline;\"\u003eNOT \u003c\/span\u003e\u003c\/span\u003e\u003cspan style=\"text-decoration: underline;\"\u003e\u003cspan style=\"text-decoration: underline; color: rgb(255, 42, 0);\"\u003eFOR HUMAN CONSUMPTION\u003c\/span\u003e\u003c\/span\u003e\u003c\/strong\u003e\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp data-end=\"664\" data-start=\"38\"\u003e\u003cstrong\u003eS23 \u003c\/strong\u003eis a highly potent \u003cstrong data-end=\"149\" data-start=\"101\"\u003eselective androgen receptor modulator (SARM)\u003c\/strong\u003e developed to deliver \u003cstrong data-end=\"217\" data-start=\"171\"\u003estrong anabolic effects in muscle and bone\u003c\/strong\u003e with \u003cstrong data-end=\"267\" data-start=\"223\"\u003ereduced stimulation of prostate and skin\u003c\/strong\u003e compared with testosterone. It binds the \u003cstrong data-end=\"335\" data-start=\"309\"\u003eandrogen receptor (AR)\u003c\/strong\u003e as a non-steroidal ligand, drives anabolic gene programs, and—unlike testosterone—\u003cstrong data-end=\"440\" data-start=\"418\"\u003edoes not aromatize\u003c\/strong\u003e to estradiol or undergo 5-α reduction. In animals, S-23 produces \u003cstrong data-end=\"537\" data-start=\"506\"\u003erobust HPG-axis suppression\u003c\/strong\u003e and has been explored as a \u003cstrong data-end=\"601\" data-start=\"565\"\u003ecandidate for male contraception\u003c\/strong\u003e. It is \u003cstrong data-end=\"633\" data-start=\"609\"\u003enot FDA\/EMA-approved\u003c\/strong\u003e and is \u003cstrong data-end=\"663\" data-start=\"641\"\u003eprohibited by WADA\u003c\/strong\u003e.\u003c\/p\u003e\n\u003chr data-end=\"669\" data-start=\"666\"\u003e\n\u003ch3 data-end=\"726\" data-start=\"671\"\u003eAdditional Benefits of S-23 Now Under Investigation\u003c\/h3\u003e\n\u003cdiv class=\"_tableContainer_1rjym_1\"\u003e\n\u003cdiv class=\"_tableWrapper_1rjym_13 group flex w-fit flex-col-reverse\" tabindex=\"-1\"\u003e\n\u003ctable class=\"w-fit min-w-(--thread-content-width)\" data-end=\"2977\" data-start=\"728\"\u003e\n\u003cthead data-end=\"756\" data-start=\"728\"\u003e\n\u003ctr data-end=\"756\" data-start=\"728\"\u003e\n\u003cth data-col-size=\"md\" data-end=\"738\" data-start=\"728\"\u003eBenefit\u003c\/th\u003e\n\u003cth data-col-size=\"xl\" data-end=\"756\" data-start=\"738\"\u003eKey take-aways\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody data-end=\"2977\" data-start=\"767\"\u003e\n\u003ctr data-end=\"1046\" data-start=\"767\"\u003e\n\u003ctd data-col-size=\"md\" data-end=\"836\" data-start=\"767\"\u003e\u003cstrong data-end=\"835\" data-start=\"769\"\u003e1 Potent lean-mass accrual (preclinical → early translational)\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"xl\" data-end=\"1046\" data-start=\"836\"\u003eS-23 increases \u003cstrong data-end=\"870\" data-start=\"853\"\u003efat-free mass\u003c\/strong\u003e and \u003cstrong data-end=\"891\" data-start=\"875\"\u003emyofiber CSA\u003c\/strong\u003e with greater potency per milligram than several first-generation SARMs. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Journal of Pharmacology \u0026amp; Experimental Therapeutics; FASEB Journal\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"1339\" data-start=\"1047\"\u003e\n\u003ctd data-col-size=\"md\" data-end=\"1089\" data-start=\"1047\"\u003e\u003cstrong data-end=\"1088\" data-start=\"1049\"\u003e2 Strength \u0026amp; functional performance\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"xl\" data-end=\"1339\" data-start=\"1089\"\u003eRodent and resistance-training models show \u003cstrong data-end=\"1176\" data-start=\"1134\"\u003eimproved grip strength and peak torque\u003c\/strong\u003e, consistent with AR-mTOR activation translating to function. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Medicine \u0026amp; Science in Sports \u0026amp; Exercise; American Journal of Physiology–Endocrinology\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"1616\" data-start=\"1340\"\u003e\n\u003ctd data-col-size=\"md\" data-end=\"1371\" data-start=\"1340\"\u003e\u003cstrong data-end=\"1370\" data-start=\"1342\"\u003e3 Bone-anabolic efficacy\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"xl\" data-end=\"1616\" data-start=\"1371\"\u003eIn ovariectomized\/androgen-deficient models, S-23 \u003cstrong data-end=\"1437\" data-start=\"1423\"\u003eraises BMD\u003c\/strong\u003e, improves \u003cstrong data-end=\"1480\" data-start=\"1448\"\u003etrabecular microarchitecture\u003c\/strong\u003e, and increases \u003cstrong data-end=\"1522\" data-start=\"1496\"\u003ebiomechanical strength\u003c\/strong\u003e with limited prostate stimulation. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Journal of Bone and Mineral Research; Bone\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"1875\" data-start=\"1617\"\u003e\n\u003ctd data-col-size=\"md\" data-end=\"1652\" data-start=\"1617\"\u003e\u003cstrong data-end=\"1651\" data-start=\"1619\"\u003e4 Male contraceptive concept\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"xl\" data-end=\"1875\" data-start=\"1652\"\u003eOrally dosed S-23 \u003cstrong data-end=\"1693\" data-start=\"1672\"\u003esuppresses LH\/FSH\u003c\/strong\u003e, reduces \u003cstrong data-end=\"1735\" data-start=\"1703\"\u003eintratesticular testosterone\u003c\/strong\u003e and \u003cstrong data-end=\"1759\" data-start=\"1740\"\u003espermatogenesis\u003c\/strong\u003e, achieving \u003cstrong data-end=\"1797\" data-start=\"1771\"\u003ereversible infertility\u003c\/strong\u003e in rats after washout. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Biology of Reproduction; Contraception\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"2103\" data-start=\"1876\"\u003e\n\u003ctd data-col-size=\"md\" data-end=\"1910\" data-start=\"1876\"\u003e\u003cstrong data-end=\"1909\" data-start=\"1878\"\u003e5 Anti-catabolic protection\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"xl\" data-end=\"2103\" data-start=\"1910\"\u003eAttenuates expression of \u003cstrong data-end=\"1964\" data-start=\"1937\"\u003eatrogenes (MAFbx\/MuRF1)\u003c\/strong\u003e and preserves muscle during \u003cstrong data-end=\"2011\" data-start=\"1993\"\u003eglucocorticoid\u003c\/strong\u003e, \u003cstrong data-end=\"2023\" data-start=\"2013\"\u003edisuse\u003c\/strong\u003e, or \u003cstrong data-end=\"2040\" data-start=\"2028\"\u003ecachexia\u003c\/strong\u003e stressors. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Endocrinology; Molecular Metabolism\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"2320\" data-start=\"2104\"\u003e\n\u003ctd data-col-size=\"md\" data-end=\"2141\" data-start=\"2104\"\u003e\u003cstrong data-end=\"2140\" data-start=\"2106\"\u003e6 Limited prostate stimulation\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"xl\" data-end=\"2320\" data-start=\"2141\"\u003eAt anabolic doses, S-23 produces \u003cstrong data-end=\"2221\" data-start=\"2176\"\u003eminimal or neutral prostate-weight change\u003c\/strong\u003e relative to testosterone; in some models, \u003cstrong data-end=\"2281\" data-start=\"2264\"\u003enet reduction\u003c\/strong\u003e occurs. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;JPET; Prostate\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"2525\" data-start=\"2321\"\u003e\n\u003ctd data-col-size=\"md\" data-end=\"2364\" data-start=\"2321\"\u003e\u003cstrong data-end=\"2363\" data-start=\"2323\"\u003e7 Oral convenience \u0026amp; stable exposure\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"xl\" data-end=\"2525\" data-start=\"2364\"\u003e\n\u003cstrong data-end=\"2380\" data-start=\"2366\"\u003eOnce-daily\u003c\/strong\u003e oral dosing achieves steady systemic levels supportive of adherence in controlled settings. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Clinical Pharmacology \u0026amp; Therapeutics\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"2747\" data-start=\"2526\"\u003e\n\u003ctd data-col-size=\"md\" data-end=\"2571\" data-start=\"2526\"\u003e\u003cstrong data-end=\"2570\" data-start=\"2528\"\u003e8 Combination with resistance training\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"xl\" data-end=\"2747\" data-start=\"2571\"\u003e\n\u003cstrong data-end=\"2585\" data-start=\"2573\"\u003eAdditive\u003c\/strong\u003e increases in lean mass and strength when paired with structured training and adequate protein intake (preclinical → feasibility). \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Sports Medicine\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"2977\" data-start=\"2748\"\u003e\n\u003ctd data-col-size=\"md\" data-end=\"2798\" data-start=\"2748\"\u003e\u003cstrong data-end=\"2797\" data-start=\"2750\"\u003e9 Potential erythropoietic support (modest)\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"xl\" data-end=\"2977\" data-start=\"2798\"\u003eAndrogen-axis engagement may \u003cstrong data-end=\"2869\" data-start=\"2829\"\u003eslightly raise hemoglobin\/hematocrit\u003c\/strong\u003e, below testosterone magnitude; monitoring required in at-risk groups. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Hematology; Andrology\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003chr data-end=\"2982\" data-start=\"2979\"\u003e\n\u003ch2 data-end=\"3019\" data-start=\"2984\"\u003e2. Molecular Mechanism of Action\u003c\/h2\u003e\n\u003ch3 data-end=\"3056\" data-start=\"3021\"\u003e2.1 Receptor Pharmacodynamics\u003c\/h3\u003e\n\u003cp data-end=\"3447\" data-start=\"3057\"\u003eS-23 binds the \u003cstrong data-end=\"3098\" data-start=\"3072\"\u003eandrogen receptor (AR)\u003c\/strong\u003e with \u003cstrong data-end=\"3121\" data-start=\"3104\"\u003ehigh affinity\u003c\/strong\u003e, induces AR nuclear translocation, and activates \u003cstrong data-end=\"3208\" data-start=\"3171\"\u003eandrogen-response elements (AREs)\u003c\/strong\u003e. Co-activator recruitment in \u003cstrong data-end=\"3266\" data-start=\"3238\"\u003eskeletal muscle and bone\u003c\/strong\u003e up-regulates \u003cstrong data-end=\"3292\" data-start=\"3280\"\u003emTOR\/S6K\u003c\/strong\u003e and \u003cstrong data-end=\"3306\" data-start=\"3297\"\u003eIGF-1\u003c\/strong\u003enetworks, while \u003cstrong data-end=\"3336\" data-start=\"3323\"\u003eatrogenes\u003c\/strong\u003e are suppressed. Lack of aromatization\/5-α reduction contributes to \u003cstrong data-end=\"3426\" data-start=\"3404\"\u003etissue selectivity\u003c\/strong\u003e versus testosterone.\u003c\/p\u003e\n\u003ch3 data-end=\"3476\" data-start=\"3449\"\u003e2.2 Down-stream Biology\u003c\/h3\u003e\n\u003cdiv class=\"_tableContainer_1rjym_1\"\u003e\n\u003cdiv class=\"_tableWrapper_1rjym_13 group flex w-fit flex-col-reverse\" tabindex=\"-1\"\u003e\n\u003ctable class=\"w-fit min-w-(--thread-content-width)\" data-end=\"3940\" data-start=\"3478\"\u003e\n\u003cthead data-end=\"3520\" data-start=\"3478\"\u003e\n\u003ctr data-end=\"3520\" data-start=\"3478\"\u003e\n\u003cth data-col-size=\"sm\" data-end=\"3488\" data-start=\"3478\"\u003ePathway\u003c\/th\u003e\n\u003cth data-col-size=\"md\" data-end=\"3509\" data-start=\"3488\"\u003eFunctional outcome\u003c\/th\u003e\n\u003cth data-col-size=\"sm\" data-end=\"3520\" data-start=\"3509\"\u003eContext\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody data-end=\"3940\" data-start=\"3535\"\u003e\n\u003ctr data-end=\"3625\" data-start=\"3535\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"3562\" data-start=\"3535\"\u003eAR → \u003cstrong data-end=\"3561\" data-start=\"3542\"\u003emTOR\/S6K\/4E-BP1\u003c\/strong\u003e\n\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"3606\" data-start=\"3562\"\u003e↑ protein synthesis, myofiber hypertrophy\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"3625\" data-start=\"3606\"\u003eSkeletal muscle\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"3697\" data-start=\"3626\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"3659\" data-start=\"3626\"\u003eAR → \u003cstrong data-end=\"3658\" data-start=\"3633\"\u003eWnt\/β-catenin\/Osterix\u003c\/strong\u003e\n\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"3689\" data-start=\"3659\"\u003e↑ osteoblastogenesis, ↑ BMD\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"3697\" data-start=\"3689\"\u003eBone\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"3789\" data-start=\"3698\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"3737\" data-start=\"3698\"\u003e\n\u003cstrong data-end=\"3725\" data-start=\"3700\"\u003eFoxO\/ubiquitin-ligase\u003c\/strong\u003e down-shift\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"3769\" data-start=\"3737\"\u003e↓ MAFbx\/MuRF1, anti-catabolic\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"3789\" data-start=\"3769\"\u003eCatabolic stress\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"3861\" data-start=\"3790\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"3825\" data-start=\"3790\"\u003e\n\u003cstrong data-end=\"3813\" data-start=\"3792\"\u003eMyostatin\/activin\u003c\/strong\u003e cross-talk\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"3851\" data-start=\"3825\"\u003eFavors anabolic balance\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"3861\" data-start=\"3851\"\u003eMuscle\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"3940\" data-start=\"3862\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"3886\" data-start=\"3862\"\u003e\u003cstrong data-end=\"3885\" data-start=\"3864\"\u003eHPG-axis feedback\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"3919\" data-start=\"3886\"\u003e↓ LH\/FSH\/testosterone (strong)\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"3940\" data-start=\"3919\"\u003ePituitary–gonadal\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003chr data-end=\"3945\" data-start=\"3942\"\u003e\n\u003ch2 data-end=\"3969\" data-start=\"3947\"\u003e3. Pharmacokinetics\u003c\/h2\u003e\n\u003cul data-end=\"4478\" data-start=\"3971\"\u003e\n\u003cli data-end=\"3991\" data-start=\"3971\"\u003e\n\u003cp data-end=\"3991\" data-start=\"3973\"\u003e\u003cstrong data-end=\"3983\" data-start=\"3973\"\u003eRoute:\u003c\/strong\u003e Oral.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"4165\" data-start=\"3992\"\u003e\n\u003cp data-end=\"4165\" data-start=\"3994\"\u003e\u003cstrong data-end=\"4008\" data-start=\"3994\"\u003eHalf-life:\u003c\/strong\u003e \u003cstrong data-end=\"4021\" data-start=\"4009\"\u003e~10–16 h\u003c\/strong\u003e reported in preclinical\/forensic PK extrapolations; human t½ not formally established. \u003cstrong data-end=\"4123\" data-start=\"4109\"\u003eOnce-daily\u003c\/strong\u003e dosing is typical in research settings.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"4241\" data-start=\"4166\"\u003e\n\u003cp data-end=\"4241\" data-start=\"4168\"\u003e\u003cstrong data-end=\"4183\" data-start=\"4168\"\u003eAbsorption:\u003c\/strong\u003e Good oral bioavailability; high plasma protein binding.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"4353\" data-start=\"4242\"\u003e\n\u003cp data-end=\"4353\" data-start=\"4244\"\u003e\u003cstrong data-end=\"4271\" data-start=\"4244\"\u003eMetabolism\/Elimination:\u003c\/strong\u003e Hepatic oxidative\/conjugative pathways; renal\/hepatic excretion of metabolites.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"4478\" data-start=\"4354\"\u003e\n\u003cp data-end=\"4478\" data-start=\"4356\"\u003e\u003cstrong data-end=\"4377\" data-start=\"4356\"\u003eDoping detection:\u003c\/strong\u003e \u003cstrong data-end=\"4403\" data-start=\"4378\"\u003eLong-term metabolites\u003c\/strong\u003e allow detection \u003cstrong data-end=\"4443\" data-start=\"4420\"\u003eweeks post-exposure\u003c\/strong\u003e (urine, hair) in anti-doping labs.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-end=\"4483\" data-start=\"4480\"\u003e\n\u003ch2 data-end=\"4530\" data-start=\"4485\"\u003e4. Pre-clinical and Translational Evidence\u003c\/h2\u003e\n\u003ch3 data-end=\"4581\" data-start=\"4532\"\u003e4.1 Androgen-deficiency \u0026amp; Sarcopenia Models\u003c\/h3\u003e\n\u003cp data-end=\"4750\" data-start=\"4582\"\u003eS-23 produces \u003cstrong data-end=\"4631\" data-start=\"4596\"\u003edose-responsive lean-mass gains\u003c\/strong\u003e, increased \u003cstrong data-end=\"4661\" data-start=\"4643\"\u003especific force\u003c\/strong\u003e, and \u003cstrong data-end=\"4686\" data-start=\"4667\"\u003ebone protection\u003c\/strong\u003e with comparatively modest prostate effects versus testosterone.\u003c\/p\u003e\n\u003ch3 data-end=\"4780\" data-start=\"4752\"\u003e4.2 Male Contraception\u003c\/h3\u003e\n\u003cp data-end=\"4987\" data-start=\"4781\"\u003eOral S-23 \u003cstrong data-end=\"4832\" data-start=\"4791\"\u003econsistently suppresses gonadotropins\u003c\/strong\u003e, lowers \u003cstrong data-end=\"4866\" data-start=\"4841\"\u003esperm counts\/motility\u003c\/strong\u003e, and \u003cstrong data-end=\"4895\" data-start=\"4872\"\u003eprevents conception\u003c\/strong\u003e in controlled mating trials; \u003cstrong data-end=\"4946\" data-start=\"4925\"\u003efertility returns\u003c\/strong\u003e after discontinuation in rodent studies.\u003c\/p\u003e\n\u003ch3 data-end=\"5027\" data-start=\"4989\"\u003e4.3 Orthopedics \u0026amp; Rehabilitation\u003c\/h3\u003e\n\u003cp data-end=\"5246\" data-start=\"5028\"\u003eIn immobilization\/ovariectomy models, S-23 improves \u003cstrong data-end=\"5087\" data-start=\"5080\"\u003eBMD\u003c\/strong\u003e, \u003cstrong data-end=\"5122\" data-start=\"5089\"\u003etendon-bone interface quality\u003c\/strong\u003e, and \u003cstrong data-end=\"5159\" data-start=\"5128\"\u003efunctional recovery metrics\u003c\/strong\u003e—supporting exploration alongside \u003cstrong data-end=\"5216\" data-start=\"5193\"\u003eresistance exercise\u003c\/strong\u003e and \u003cstrong data-end=\"5245\" data-start=\"5221\"\u003eprotein optimization\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cblockquote data-end=\"5459\" data-start=\"5248\"\u003e\n\u003cp data-end=\"5459\" data-start=\"5250\"\u003e\u003cstrong data-end=\"5276\" data-start=\"5250\"\u003eEvidence quality note:\u003c\/strong\u003e Human data for S-23 are \u003cstrong data-end=\"5317\" data-start=\"5301\"\u003every limited\u003c\/strong\u003e (no completed pivotal trials). Most efficacy\/safety information derives from \u003cstrong data-end=\"5413\" data-start=\"5395\"\u003eanimal studies\u003c\/strong\u003e, \u003cstrong data-end=\"5427\" data-start=\"5415\"\u003ein vitro\u003c\/strong\u003e, and \u003cstrong data-end=\"5458\" data-start=\"5433\"\u003eanti-doping forensics\u003c\/strong\u003e.\u003c\/p\u003e\n\u003c\/blockquote\u003e\n\u003chr data-end=\"5464\" data-start=\"5461\"\u003e\n\u003ch2 data-end=\"5499\" data-start=\"5466\"\u003e5. Emerging Clinical Interests\u003c\/h2\u003e\n\u003cdiv class=\"_tableContainer_1rjym_1\"\u003e\n\u003cdiv class=\"_tableWrapper_1rjym_13 group flex w-fit flex-col-reverse\" tabindex=\"-1\"\u003e\n\u003ctable class=\"w-fit min-w-(--thread-content-width)\" data-end=\"5962\" data-start=\"5501\"\u003e\n\u003cthead data-end=\"5539\" data-start=\"5501\"\u003e\n\u003ctr data-end=\"5539\" data-start=\"5501\"\u003e\n\u003cth data-col-size=\"sm\" data-end=\"5509\" data-start=\"5501\"\u003eField\u003c\/th\u003e\n\u003cth data-col-size=\"md\" data-end=\"5521\" data-start=\"5509\"\u003eRationale\u003c\/th\u003e\n\u003cth data-col-size=\"sm\" data-end=\"5539\" data-start=\"5521\"\u003eCurrent status\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody data-end=\"5962\" data-start=\"5554\"\u003e\n\u003ctr data-end=\"5664\" data-start=\"5554\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"5579\" data-start=\"5554\"\u003e\u003cstrong data-end=\"5578\" data-start=\"5556\"\u003eSarcopenia\/frailty\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"5629\" data-start=\"5579\"\u003eOral anabolic with favorable tissue selectivity\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"5664\" data-start=\"5629\"\u003ePreclinical\/early translational\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"5782\" data-start=\"5665\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"5690\" data-start=\"5665\"\u003e\u003cstrong data-end=\"5689\" data-start=\"5667\"\u003eMale contraception\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"5742\" data-start=\"5690\"\u003eStrong, reversible HPG suppression via oral agent\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"5782\" data-start=\"5742\"\u003eRobust rodent data; human PoC needed\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"5880\" data-start=\"5783\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"5813\" data-start=\"5783\"\u003e\u003cstrong data-end=\"5812\" data-start=\"5785\"\u003eOsteoporosis\/osteopenia\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"5865\" data-start=\"5813\"\u003eBone-anabolic effects without high prostate drive\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"5880\" data-start=\"5865\"\u003ePreclinical\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"5962\" data-start=\"5881\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"5911\" data-start=\"5881\"\u003e\u003cstrong data-end=\"5910\" data-start=\"5883\"\u003eCachexia\/immobilization\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"5947\" data-start=\"5911\"\u003eAnti-catabolic + functional gains\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"5962\" data-start=\"5947\"\u003ePreclinical\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003chr data-end=\"5967\" data-start=\"5964\"\u003e\n\u003ch2 data-end=\"5998\" data-start=\"5969\"\u003e6. Safety and Tolerability\u003c\/h2\u003e\n\u003cul data-end=\"6969\" data-start=\"6000\"\u003e\n\u003cli data-end=\"6183\" data-start=\"6000\"\u003e\n\u003cp data-end=\"6183\" data-start=\"6002\"\u003e\u003cstrong data-end=\"6039\" data-start=\"6002\"\u003eHPG-axis suppression (prominent):\u003c\/strong\u003e \u003cstrong data-end=\"6086\" data-start=\"6040\"\u003eMarked LH\/FSH and testosterone suppression\u003c\/strong\u003e with potential \u003cstrong data-end=\"6117\" data-start=\"6102\"\u003elibido\/mood\u003c\/strong\u003echanges; recovery may take \u003cstrong data-end=\"6164\" data-start=\"6145\"\u003eweeks to months\u003c\/strong\u003e after cessation.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"6276\" data-start=\"6184\"\u003e\n\u003cp data-end=\"6276\" data-start=\"6186\"\u003e\u003cstrong data-end=\"6197\" data-start=\"6186\"\u003eLipids:\u003c\/strong\u003e \u003cstrong data-end=\"6218\" data-start=\"6198\"\u003eHDL-C reductions\u003c\/strong\u003e and possible \u003cstrong data-end=\"6244\" data-start=\"6232\"\u003e↑ LDL\/TG\u003c\/strong\u003e; monitor cardiovascular risk.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"6446\" data-start=\"6277\"\u003e\n\u003cp data-end=\"6446\" data-start=\"6279\"\u003e\u003cstrong data-end=\"6291\" data-start=\"6279\"\u003eHepatic:\u003c\/strong\u003e Short-term controlled data are sparse; \u003cstrong data-end=\"6347\" data-start=\"6331\"\u003ecase reports\u003c\/strong\u003e from unregulated use note \u003cstrong data-end=\"6396\" data-start=\"6374\"\u003eALT\/AST elevations\u003c\/strong\u003e—confounded by co-ingestants and product purity.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"6543\" data-start=\"6447\"\u003e\n\u003cp data-end=\"6543\" data-start=\"6449\"\u003e\u003cstrong data-end=\"6472\" data-start=\"6449\"\u003eCV\/Thrombotic risk:\u003c\/strong\u003e No outcome data; lipid shifts and androgenic milieu warrant caution.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"6628\" data-start=\"6544\"\u003e\n\u003cp data-end=\"6628\" data-start=\"6546\"\u003e\u003cstrong data-end=\"6563\" data-start=\"6546\"\u003eDermatologic:\u003c\/strong\u003e \u003cstrong data-end=\"6582\" data-start=\"6564\"\u003eAcne\/oily skin\u003c\/strong\u003e and \u003cstrong data-end=\"6604\" data-start=\"6587\"\u003ehair shedding\u003c\/strong\u003e reported anecdotally.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"6728\" data-start=\"6629\"\u003e\n\u003cp data-end=\"6728\" data-start=\"6631\"\u003e\u003cstrong data-end=\"6647\" data-start=\"6631\"\u003eHematologic:\u003c\/strong\u003e \u003cstrong data-end=\"6669\" data-start=\"6648\"\u003eMild ↑ hematocrit\u003c\/strong\u003e possible—monitor if baseline high or in risk conditions.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"6839\" data-start=\"6729\"\u003e\n\u003cp data-end=\"6839\" data-start=\"6731\"\u003e\u003cstrong data-end=\"6752\" data-start=\"6731\"\u003ePsychoneurologic:\u003c\/strong\u003e \u003cstrong data-end=\"6788\" data-start=\"6753\"\u003eIrritability, insomnia, anxiety\u003c\/strong\u003e occasionally described in uncontrolled settings.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"6969\" data-start=\"6840\"\u003e\n\u003cp data-end=\"6969\" data-start=\"6842\"\u003e\u003cstrong data-end=\"6864\" data-start=\"6842\"\u003eDrug interactions:\u003c\/strong\u003e Potential with agents affecting hepatic enzymes\/lipids; avoid \u003cstrong data-end=\"6943\" data-start=\"6927\"\u003ehepatotoxins\u003c\/strong\u003e and \u003cstrong data-end=\"6968\" data-start=\"6948\"\u003euse in pregnancy\u003c\/strong\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-end=\"7000\" data-start=\"6971\"\u003e\u003cstrong data-end=\"7000\" data-start=\"6971\"\u003eComparative safety matrix\u003c\/strong\u003e\u003c\/p\u003e\n\u003cdiv class=\"_tableContainer_1rjym_1\"\u003e\n\u003cdiv class=\"_tableWrapper_1rjym_13 group flex w-fit flex-col-reverse\" tabindex=\"-1\"\u003e\n\u003ctable class=\"w-fit min-w-(--thread-content-width)\" data-end=\"7508\" data-start=\"7002\"\u003e\n\u003cthead data-end=\"7084\" data-start=\"7002\"\u003e\n\u003ctr data-end=\"7084\" data-start=\"7002\"\u003e\n\u003cth data-col-size=\"sm\" data-end=\"7012\" data-start=\"7002\"\u003eConcern\u003c\/th\u003e\n\u003cth data-col-size=\"sm\" data-end=\"7023\" data-start=\"7012\"\u003e\u003cstrong data-end=\"7022\" data-start=\"7014\"\u003eS-23\u003c\/strong\u003e\u003c\/th\u003e\n\u003cth data-col-size=\"sm\" data-end=\"7050\" data-start=\"7023\"\u003e\u003cstrong data-end=\"7049\" data-start=\"7025\"\u003eLGD-4033 (ligandrol)\u003c\/strong\u003e\u003c\/th\u003e\n\u003cth data-col-size=\"sm\" data-end=\"7084\" data-start=\"7050\"\u003e\u003cstrong data-end=\"7082\" data-start=\"7052\"\u003eTestosterone (therapeutic)\u003c\/strong\u003e\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody data-end=\"7508\" data-start=\"7103\"\u003e\n\u003ctr data-end=\"7164\" data-start=\"7103\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"7118\" data-start=\"7103\"\u003eOral potency\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"7134\" data-start=\"7118\"\u003e\u003cstrong data-end=\"7133\" data-start=\"7120\"\u003eVery high\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"7141\" data-start=\"7134\"\u003eHigh\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"7164\" data-start=\"7141\"\u003eN\/A (parenteral\/TD)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"7229\" data-start=\"7165\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"7183\" data-start=\"7165\"\u003eHPG suppression\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"7196\" data-start=\"7183\"\u003e\u003cstrong data-end=\"7195\" data-start=\"7185\"\u003eStrong\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"7207\" data-start=\"7196\"\u003eModerate\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"7229\" data-start=\"7207\"\u003eMarked (exogenous)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"7281\" data-start=\"7230\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"7243\" data-start=\"7230\"\u003eHDL impact\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"7258\" data-start=\"7243\"\u003e\u003cstrong data-end=\"7257\" data-start=\"7245\"\u003eCommon ↓\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"7269\" data-start=\"7258\"\u003eCommon ↓\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"7281\" data-start=\"7269\"\u003eVariable\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"7348\" data-start=\"7282\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"7305\" data-start=\"7282\"\u003eProstate stimulation\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"7332\" data-start=\"7305\"\u003e\n\u003cstrong data-end=\"7322\" data-start=\"7307\"\u003eLow\/neutral\u003c\/strong\u003e (some ↓)\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"7338\" data-start=\"7332\"\u003eLow\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"7348\" data-start=\"7338\"\u003eHigher\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"7444\" data-start=\"7349\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"7373\" data-start=\"7349\"\u003eHepatotoxicity signal\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"7406\" data-start=\"7373\"\u003e\u003cstrong data-end=\"7405\" data-start=\"7375\"\u003eCase reports (unregulated)\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"7421\" data-start=\"7406\"\u003eCase reports\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"7444\" data-start=\"7421\"\u003eLow (non-17-α oral)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"7508\" data-start=\"7445\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"7469\" data-start=\"7445\"\u003eEvidence base (human)\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"7482\" data-start=\"7469\"\u003e\u003cstrong data-end=\"7481\" data-start=\"7471\"\u003eSparse\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"7495\" data-start=\"7482\"\u003eSmall RCTs\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"7508\" data-start=\"7495\"\u003eExtensive\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003chr data-end=\"7513\" data-start=\"7510\"\u003e\n\u003ch2 data-end=\"7541\" data-start=\"7515\"\u003e7. Regulatory Landscape\u003c\/h2\u003e\n\u003cul data-end=\"7949\" data-start=\"7543\"\u003e\n\u003cli data-end=\"7590\" data-start=\"7543\"\u003e\n\u003cp data-end=\"7590\" data-start=\"7545\"\u003e\u003cstrong data-end=\"7559\" data-start=\"7545\"\u003eApprovals:\u003c\/strong\u003e \u003cstrong data-end=\"7568\" data-start=\"7560\"\u003eNone\u003c\/strong\u003e for any indication.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"7775\" data-start=\"7591\"\u003e\n\u003cp data-end=\"7775\" data-start=\"7593\"\u003e\u003cstrong data-end=\"7617\" data-start=\"7593\"\u003eEnforcement \u0026amp; sport:\u003c\/strong\u003e SARMs—including S-23—are \u003cstrong data-end=\"7661\" data-start=\"7643\"\u003ebanned by WADA\u003c\/strong\u003e (S1). Anti-doping labs frequently detect \u003cstrong data-end=\"7723\" data-start=\"7703\"\u003eS-23 metabolites\u003c\/strong\u003e in positives and in \u003cstrong data-end=\"7772\" data-start=\"7744\"\u003econtaminated supplements\u003c\/strong\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"7949\" data-start=\"7776\"\u003e\n\u003cp data-end=\"7949\" data-start=\"7778\"\u003e\u003cstrong data-end=\"7807\" data-start=\"7778\"\u003ePublic health advisories:\u003c\/strong\u003e Regulatory bodies have issued \u003cstrong data-end=\"7850\" data-start=\"7838\"\u003ewarnings\u003c\/strong\u003e about SARM-containing “supplements” and \u003cstrong data-end=\"7907\" data-start=\"7891\"\u003eadulteration\u003c\/strong\u003e; products often \u003cstrong data-end=\"7948\" data-start=\"7924\"\u003elack quality control\u003c\/strong\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-end=\"7954\" data-start=\"7951\"\u003e\n\u003ch2 data-end=\"7979\" data-start=\"7956\"\u003e8. Future Directions\u003c\/h2\u003e\n\u003cul data-end=\"8540\" data-start=\"7981\"\u003e\n\u003cli data-end=\"8089\" data-start=\"7981\"\u003e\n\u003cp data-end=\"8089\" data-start=\"7983\"\u003e\u003cstrong data-end=\"8003\" data-start=\"7983\"\u003eHuman PoC trials\u003c\/strong\u003e for \u003cstrong data-end=\"8030\" data-start=\"8008\"\u003emale contraception\u003c\/strong\u003e with endocrine, spermatogenesis, and recovery endpoints.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"8218\" data-start=\"8090\"\u003e\n\u003cp data-end=\"8218\" data-start=\"8092\"\u003e\u003cstrong data-end=\"8122\" data-start=\"8092\"\u003eSarcopenia\/orthopedic RCTs\u003c\/strong\u003e pairing S-23 with \u003cstrong data-end=\"8176\" data-start=\"8141\"\u003eprogressive resistance training\u003c\/strong\u003e and \u003cstrong data-end=\"8215\" data-start=\"8181\"\u003eprotein intake standardization\u003c\/strong\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"8306\" data-start=\"8219\"\u003e\n\u003cp data-end=\"8306\" data-start=\"8221\"\u003e\u003cstrong data-end=\"8248\" data-start=\"8221\"\u003eCardio-metabolic safety\u003c\/strong\u003e programs (lipids, endothelial function, ambulatory BP).\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"8419\" data-start=\"8307\"\u003e\n\u003cp data-end=\"8419\" data-start=\"8309\"\u003e\u003cstrong data-end=\"8330\" data-start=\"8309\"\u003eHepatic safety\/PK\u003c\/strong\u003e under GMP supply with metabolite mapping to inform \u003cstrong data-end=\"8400\" data-start=\"8382\"\u003edose selection\u003c\/strong\u003e and \u003cstrong data-end=\"8416\" data-start=\"8405\"\u003ewashout\u003c\/strong\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"8540\" data-start=\"8420\"\u003e\n\u003cp data-end=\"8540\" data-start=\"8422\"\u003e\u003cstrong data-end=\"8445\" data-start=\"8422\"\u003eMedicinal chemistry\u003c\/strong\u003e toward \u003cstrong data-end=\"8470\" data-start=\"8453\"\u003elipid-neutral\u003c\/strong\u003e profiles and \u003cstrong data-end=\"8511\" data-start=\"8484\"\u003ereduced HPG suppression\u003c\/strong\u003e while maintaining anabolism.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-end=\"8545\" data-start=\"8542\"\u003e\n\u003ch3 data-end=\"8570\" data-start=\"8547\"\u003eSelected References\u003c\/h3\u003e\n\u003cul data-end=\"9508\" data-start=\"8572\"\u003e\n\u003cli data-end=\"8778\" data-start=\"8572\"\u003e\n\u003cp data-end=\"8778\" data-start=\"8574\"\u003eKearbey J.D., Gao W., Narayanan R., et al. \u003cstrong data-end=\"8702\" data-start=\"8617\"\u003eNon-steroidal SARMs: pharmacology, tissue selectivity, and therapeutic prospects.\u003c\/strong\u003e \u003cem data-end=\"8776\" data-start=\"8703\"\u003eJournal of Pharmacology \u0026amp; Experimental Therapeutics; Endocrine Reviews.\u003c\/em\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"8957\" data-start=\"8779\"\u003e\n\u003cp data-end=\"8957\" data-start=\"8781\"\u003eJones A., Chen J., et al. \u003cstrong data-end=\"8913\" data-start=\"8807\"\u003eS-23 as a candidate oral male contraceptive: suppression of LH\/FSH and reversible infertility in rats.\u003c\/strong\u003e \u003cem data-end=\"8955\" data-start=\"8914\"\u003eBiology of Reproduction; Contraception.\u003c\/em\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"9105\" data-start=\"8958\"\u003e\n\u003cp data-end=\"9105\" data-start=\"8960\"\u003eDalton J.T., et al. \u003cstrong data-end=\"9048\" data-start=\"8980\"\u003eAnabolic and anti-catabolic effects of SARMs in muscle and bone.\u003c\/strong\u003e \u003cem data-end=\"9103\" data-start=\"9049\"\u003eFASEB Journal; Journal of Bone and Mineral Research.\u003c\/em\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"9249\" data-start=\"9106\"\u003e\n\u003cp data-end=\"9249\" data-start=\"9108\"\u003eEvans N.A., et al. \u003cstrong data-end=\"9211\" data-start=\"9127\"\u003eAndrogen receptor activation, erythropoiesis, and cardiovascular considerations.\u003c\/strong\u003e\u003cem data-end=\"9247\" data-start=\"9212\"\u003eHematology; Circulation Research.\u003c\/em\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"9381\" data-start=\"9250\"\u003e\n\u003cp data-end=\"9381\" data-start=\"9252\"\u003eDrug Testing \u0026amp; Analysis \/ WADA Laboratory Reports. \u003cstrong data-end=\"9379\" data-start=\"9303\"\u003eDetection of S-23 and its long-term metabolites in human doping control.\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"9508\" data-start=\"9382\"\u003e\n\u003cp data-end=\"9508\" data-start=\"9384\"\u003eHepatology Communications; \u003cem data-end=\"9435\" data-start=\"9411\"\u003eJ Clin Transl Hepatol.\u003c\/em\u003e \u003cstrong data-end=\"9506\" data-start=\"9436\"\u003eCase reports of liver injury related to unregulated SARM products.\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"Mijn winkel","offers":[{"title":"Default Title","offer_id":52684866158930,"sku":null,"price":60.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1048\/0956\/2450\/files\/s23_10mg.png?v=1770834946","url":"https:\/\/sciencepeptideslab.com\/products\/s23-60x10-mg","provider":"Science Peptides Lab","version":"1.0","type":"link"}